Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer With Bone Metastasis”

238 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 238 results

Not applicableStudy completedNCT03223727
What this trial is testing

Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223

Who this might be right for
Prostate Cancer MetastaticBone Metastases
The Netherlands Cancer Institute 100
Not applicableUnknownNCT03988686
What this trial is testing

Testing Radical Prostatectomy in Chinese Men With Prostate Cancer and oligoMetastases to the Bone

Who this might be right for
Prostate Cancer Metastatic
Fudan University 120
Not applicableEnded earlyNCT00918645
What this trial is testing

Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis

Who this might be right for
Metastatic CancerProstate Cancer
University of California, Davis 13
Testing effectiveness (Phase 2)Study completedNCT03336983
What this trial is testing

Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients

Who this might be right for
Prostate CancerBone Metastases
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 126
Testing effectiveness (Phase 2)UnknownNCT02484339
What this trial is testing

Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT)

Who this might be right for
Prostate Carcinoma
University Hospital Freiburg 274
Large-scale testing (Phase 3)Ended earlyNCT00294437
What this trial is testing

ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

Who this might be right for
Prostate Cancer
Central European Cooperative Oncology Group 376
Early research (Phase 1)WithdrawnNCT06982222
What this trial is testing

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+4 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT01810770
What this trial is testing

Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis

Who this might be right for
Prostatic Neoplasms
Bayer 243
Not applicableStudy completedNCT01062503
What this trial is testing

Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC

Who this might be right for
Metastatic Prostate CancerBone Metastasis
University Health Network, Toronto 48
Testing effectiveness (Phase 2)Study completedNCT00390468
What this trial is testing

Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerPainProstate Cancer
National Cancer Institute (NCI) 18
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Testing effectiveness (Phase 2)Study completedNCT02023697
What this trial is testing

Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone

Who this might be right for
Prostatic Neoplasms
Bayer 391
Large-scale testing (Phase 3)Study completedNCT00089674
What this trial is testing

AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Amgen 1,468
Testing effectiveness (Phase 2)Study completedNCT02499835
What this trial is testing

Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Soft Tissues+4 more
University of Wisconsin, Madison 66
Early research (Phase 1)Ended earlyNCT03043989
What this trial is testing

Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Not applicableStudy completedNCT01992016
What this trial is testing

A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine

Who this might be right for
Adenocarcinoma of the ProstateBone MetastasesSoft Tissue Metastases+4 more
University of Colorado, Denver 11
Testing effectiveness (Phase 2)Study completedNCT03707184
What this trial is testing

Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone

Who this might be right for
Metastatic Prostate CarcinomaProstate Carcinoma Metastatic in the BoneStage IV Prostate Cancer
University of Utah 17
Testing effectiveness (Phase 2)Study completedNCT02601014
What this trial is testing

Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7

Who this might be right for
Prostate CancerRecurrent Prostate CarcinomaStage IV Prostate Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Not applicableUnknownNCT03414437
What this trial is testing

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

Who this might be right for
Prostate Cancer Metastatic
Carolina Research Professionals, LLC 31
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Next Page